These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 27113480)

  • 21. MicroRNA-124 Promotes Intestinal Inflammation by Targeting Aryl Hydrocarbon Receptor in Crohn's Disease.
    Zhao Y; Ma T; Chen W; Chen Y; Li M; Ren L; Chen J; Cao R; Feng Y; Zhang H; Shi R
    J Crohns Colitis; 2016 Jun; 10(6):703-12. PubMed ID: 26802080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid.
    Kabeerdoss J; Jayakanthan P; Pugazhendhi S; Ramakrishna BS
    Indian J Med Res; 2015 Jul; 142(1):23-32. PubMed ID: 26261163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epithelial-mesenchymal transition and its role in the pathogenesis of colorectal cancer.
    Zhu QC; Gao RY; Wu W; Qin HL
    Asian Pac J Cancer Prev; 2013; 14(5):2689-98. PubMed ID: 23803016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis.
    Pathak S; Grillo AR; Scarpa M; Brun P; D'Incà R; Nai L; Banerjee A; Cavallo D; Barzon L; Palù G; Sturniolo GC; Buda A; Castagliuolo I
    Exp Mol Med; 2015 May; 47(5):e164. PubMed ID: 25998827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-31 Reduces Inflammatory Signaling and Promotes Regeneration in Colon Epithelium, and Delivery of Mimics in Microspheres Reduces Colitis in Mice.
    Tian Y; Xu J; Li Y; Zhao R; Du S; Lv C; Wu W; Liu R; Sheng X; Song Y; Bi X; Li G; Li M; Wu X; Lou P; You H; Cui W; Sun J; Shuai J; Ren F; Zhang B; Guo M; Hou X; Wu K; Xue L; Zhang H; Plikus MV; Cong Y; Lengner CJ; Liu Z; Yu Z
    Gastroenterology; 2019 Jun; 156(8):2281-2296.e6. PubMed ID: 30779922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins.
    Kucharzik T; Walsh SV; Chen J; Parkos CA; Nusrat A
    Am J Pathol; 2001 Dec; 159(6):2001-9. PubMed ID: 11733350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of miR-22 in intestinal mucosa tissues and peripheral blood CD4+ T cells of inflammatory bowel disease.
    Pei XF; Cao LL; Huang F; Qiao X; Yu J; Ye H; Xi CL; Zhou QC; Zhang GF; Gong ZL
    Pathol Res Pract; 2018 Aug; 214(8):1095-1104. PubMed ID: 29880327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole genome gene expression meta-analysis of inflammatory bowel disease colon mucosa demonstrates lack of major differences between Crohn's disease and ulcerative colitis.
    Granlund Av; Flatberg A; Østvik AE; Drozdov I; Gustafsson BI; Kidd M; Beisvag V; Torp SH; Waldum HL; Martinsen TC; Damås JK; Espevik T; Sandvik AK
    PLoS One; 2013; 8(2):e56818. PubMed ID: 23468882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrated miRNA and mRNA expression profiling in inflamed colon of patients with ulcerative colitis.
    Van der Goten J; Vanhove W; Lemaire K; Van Lommel L; Machiels K; Wollants WJ; De Preter V; De Hertogh G; Ferrante M; Van Assche G; Rutgeerts P; Schuit F; Vermeire S; Arijs I
    PLoS One; 2014; 9(12):e116117. PubMed ID: 25546151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders.
    Papa Gobbi R; De Francesco N; Bondar C; Muglia C; Chirdo F; Rumbo M; Rocca A; Toscano MA; Sambuelli A; Rabinovich GA; Docena GH
    Biofactors; 2016; 42(1):93-105. PubMed ID: 26891020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Annexin A2 expression in intestinal mucosa of patients with inflammatory bowel disease and its clinical implications].
    Zhang Z; Zhao X; Lv C; Li C; Zhi F
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1548-52. PubMed ID: 23174572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: evidence of altered expression of FasL and perforin cytotoxic pathways.
    Souza HS; Tortori CJ; Castelo-Branco MT; Carvalho AT; Margallo VS; Delgado CF; Dines I; Elia CC
    Int J Colorectal Dis; 2005 May; 20(3):277-86. PubMed ID: 15503066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New insights into the pathogenesis of inflammatory bowel disease: transcription factors analysis in bioptic tissues from pediatric patients.
    Pierdomenico M; Stronati L; Costanzo M; Vitali R; Di Nardo G; Nuti F; Oliva S; Cucchiara S; Negroni A
    J Pediatr Gastroenterol Nutr; 2011 Mar; 52(3):271-9. PubMed ID: 21336161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A microRNA signature in pediatric ulcerative colitis: deregulation of the miR-4284/CXCL5 pathway in the intestinal epithelium.
    Koukos G; Polytarchou C; Kaplan JL; Oikonomopoulos A; Ziring D; Hommes DW; Wahed R; Kokkotou E; Pothoulakis C; Winter HS; Iliopoulos D
    Inflamm Bowel Dis; 2015 May; 21(5):996-1005. PubMed ID: 25738378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-19b downregulates intestinal SOCS3 to reduce intestinal inflammation in Crohn's disease.
    Cheng X; Zhang X; Su J; Zhang Y; Zhou W; Zhou J; Wang C; Liang H; Chen X; Shi R; Zen K; Zhang CY; Zhang H
    Sci Rep; 2015 May; 5():10397. PubMed ID: 25997679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulation of miR-200b-targeting Slug axis by cyclosporine A in human gingival fibroblasts.
    Lin T; Yu CC; Hsieh PL; Liao YW; Yu CH; Chen CJ
    J Formos Med Assoc; 2018 Dec; 117(12):1072-1077. PubMed ID: 30449457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined segregation and linkage analysis of inflammatory bowel disease in the IBD1 region using severity to characterise Crohn's disease and ulcerative colitis. On behalf of the GISC.
    Forabosco P; Collins A; Latiano A; Annese V; Clementi M; Andriulli A; Fortina P; Devoto M; Morton NE
    Eur J Hum Genet; 2000 Nov; 8(11):846-52. PubMed ID: 11093274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impairment of Tissue-Resident Mesenchymal Stem Cells in Chronic Ulcerative Colitis and Crohn's Disease.
    Grim C; Noble R; Uribe G; Khanipov K; Johnson P; Koltun WA; Watts T; Fofanov Y; Yochum GS; Powell DW; Beswick EJ; Pinchuk IV
    J Crohns Colitis; 2021 Aug; 15(8):1362-1375. PubMed ID: 33506258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?
    Fernandes P; MacSharry J; Darby T; Fanning A; Shanahan F; Houston A; Brint E
    Clin Exp Immunol; 2016 Mar; 183(3):358-68. PubMed ID: 26462859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.